Trailing-twelve-month (TTM) revenue is $208.71 Billion with a year-over-year growth of +11.17%. Revenue represents the total income generated from the company's primary business operations.
Trailing-12-month revenue adds these four fiscal quarters. Amounts are in USD, rounded only to whole currency units.
| Fiscal period | Revenue | Source |
|---|---|---|
| Q3 FY2025Period ended 2025-09-30 | $48,169,000,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2025-11-06 |
| Q4 FY2025Period ended 2025-12-31 | $45,787,000,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-02-24 |
| Q1 FY2026Period ended 2026-03-31 | $47,556,000,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-05-07 |
| Q2 FY2026Period ended 2026-06-30 | $67,199,000,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-08-06 |
| TTM revenue | $208,711,000,000 |
Current P/S: $425,823,996,000 market capitalization ÷ $208,711,000,000 TTM revenue = 2.04x.
Market capitalization source: FMP quote. Quote observed 2026-09-09T20:00:00.000Z. Latest revenue period ended 2026-06-30.
Current market capitalization comes from the quote provider. EPS weighted-average shares are a separate measure.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.
Reported quarterly revenue; no daily interpolation. Q2 FY2026 (2026-06-30): $67.20B.
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters Quote observation: 2026-09-09T20:00:00.000Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-09-09.
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20202020-12-30 · USD | FY20212021-12-30 · USD | FY20222022-12-30 · USD | FY20232023-12-30 · USD | FY20242024-12-31 · USD | FY20252025-12-31 · USD |
|---|---|---|---|---|---|---|
| All Other | $77M | $124M | $116M | $133M | $132M | N/A |
| All Other Segments | N/A | N/A | N/A |
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20202020-12-30 · USD | FY20212021-12-30 · USD | FY20222022-12-30 · USD | FY20232023-12-30 · USD | FY20242024-12-31 · USD | FY20252025-12-31 · USD |
|---|---|---|---|---|---|---|
| Downstream Segment | N/A | N/A | N/A | N/A | N/A | $72.5B |
| Global | N/A | N/A |
$208.71B
$208.71 Billion
+11.17%
vs. $187.74B a year ago (TTM)
+12.46%
5 Year compound annual growth rate
1 Year
+11.17%
3 Year
+1.10%
5 Year
+12.46%
10 Year
+6.45%
15 Year
(0.55%)
20 Year
(0.33%)
CAGR shows the annualized growth rate over the specified period, smoothing out year-to-year volatility.
| Year | Revenue | YoY Change | % Change |
|---|---|---|---|
| 2025 | $184.43B | ($8.98B) | (4.64%) |
| 2024 | $193.41B | ($3.50B) | (1.78%) |
| 2023 | $196.91B | ($38.80B) | (16.46%) |
| 2022 | $235.72B | +$80.11B | +51.48% |
| 2021 | $155.61B | +$61.13B | +64.71% |
| 2020 |
TTM Growth
+11.17%
3-Year CAGR
+1.10%
5-Year CAGR
+12.46%
Revenue growth vs the same fiscal quarter in the prior fiscal year, last 40 comparable quarters.
Current FMP quote-based enterprise value / four-quarter revenue Quote observation: 2026-09-09T20:00:00.000Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-09-09.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
| N/A |
| N/A |
| $644M |
| Downstream | $68.1B | $111.5B | $172.3B | $151.0B | $146.4B | $72.5B |
|---|
| Upstream | $26.3B | $44.0B | $63.3B | $45.7B | $46.8B | $45.5B |
|---|
| N/A |
| $132M |
| N/A |
| International | $57.4B | $86.5B | $128.4B | $108.2B | $108.0B | N/A |
|---|
| United States | $37.0B | $69.1B | $107.4B | $88.7B | $85.3B | N/A |
|---|
| Upstream Segment | N/A | N/A | N/A | N/A | N/A | $45.5B |
|---|
| $94.47B |
| ($45.39B) |
| (32.46%) |
| 2019 | $139.87B | ($19.04B) | (11.98%) |
| 2018 | $158.90B | +$24.23B | +17.99% |
| 2017 | $134.67B | +$24.46B | +22.19% |
| 2016 | $110.22B | ($19.71B) | (15.17%) |
